Existing Evidence

According to the CDC, EPT should be available to clinicians as an option for partner treatment. EPT represents an additional strategy for partner management that does not replace other strategies such as provider-assisted referral, when available. (CDC 2021).

For more information, check the FAQs.

*CDC 2021,

*CDC 2018

*RR0.71, 95% CI 0.56-0.89 (Ferreira 2013). Compared to simple patient referral.

*When compared with simple patient referral in people with chlamydia or gonorrhoea (EPT treated patients resulted in mean of 0.43 extra partner treated, 95% CI 0.28 to 0.58) (Ferriera 2013).

*Gift TL 2011

*Vaidya et al. 2014

References

Ferreira, Adel, Taryn Young, Catherine Mathews, Moleen Zunza, and Nicola Low. 2013. “Strategies for Partner Notification for Sexually Transmitted Infections, Including HIV.” Cochrane Database of Systematic Reviews , no. 10. https://doi.org/10.1002/14651858.CD002843.pub2 .

Vaidya, Sheila, Kimberly Johnson, Meighan Rogers, Denis Nash, and Julia A. Schillinger. 2014. “Predictors of Index Patient Acceptance of Expedited Partner Therapy for Chlamydia Trachomatis Infection and Reasons for Refusal, Sexually Transmitted Disease Clinics, New York City, 2011 to 2012.” Sexually Transmitted Diseases 41 (11): 690–94.

Gift TL, Kissinger P, Mohammed H, Leichliter JS, Hogben M, Golden MR. The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of chlamydia or gonorrhea. Sex Transm Dis. 2011 Nov;38(11):1067-73. doi: 10.1097/OLQ.0b013e31822e9192. PMID: 21992986.

RethinkSTICare@gmail.com